Effect of protamine on cation-selective permeability in hamster medullary thick ascending limb of Henle's loop.
To estimate the contribution of the paracellular shunt pathway to cation-selective permeability in the hamster medullary thick ascending limb of Henle's loop, we observed the effect of protamine, a selective blocker of paracellular conductance, on salt-diffusion voltage (dVT) in the isolated nephron segment perfused in vitro. When 300 microg/ml protamine was added to the lumen, the lumen-positive dVT generated upon reduction of the lumen NaCl concentration was decreased from 5.1 +/- 0.9 to 0.8 +/- 0.8 mV and the calculated Na+/Cl- permeability ratio was decreased from 1.40 +/- 0.14 to 0.86 +/- 0.08. Although the effect of protamine persisted after removal of the agent from the lumen, addition of 30 U/ml heparin, which neutralizes protamine, returned the dVT toward the control level. This effect was almost the same when the orientation of the imposed NaCl gradient was reversed. Protamine exhibited a similar effect on dVT in the presence of ouabain added to the bath. Protamine was without effect from the bath. Protamine did not affect the basel VT perfused with the control solution. Increased VT by decreasing perfusion pressure was inhibited by adding protamine from the lumen. These observations suggest that the paracellular pathway contributes to the cation selectivity of the medullary thick ascending limb. The cation selectivity of the paracellular shunt pathway may mainly account for the changes in VT which are either dependent on the luminal flow rate or transmural NaCl concentration gradient, while it may not contribute to the basal level of VT.
Koyama
S
S
Department of Pharmacology, Jichi Medical School, Kawachi, Tochigi, Japan.
Yoshitomi
K
K
Imai
M
M
D000818:Animals; D002412:Cations / Q000493:pharmacokinetics; D002463:Cell Membrane Permeability / Q000187:drug effects; D006224:Cricetinae; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006494:Heparin Antagonists / Q000494:pharmacology*; D017136:Ion Transport / Q000187:drug effects / Q000502:physiology; D007679:Kidney Medulla / Q000187:drug effects / Q000378:metabolism; D008138:Loop of Henle / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008647:Mesocricetus; D011479:Protamines / Q000494:pharmacology*; D012964:Sodium / Q000493:pharmacokinetics*; D012965:Sodium Chloride / Q000493:pharmacokinetics
D002412:Cations; D006494:Heparin Antagonists; D011479:Protamines; D012965:Sodium Chloride; D006493:Heparin; D012964:Sodium